Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Clinical Eligibility Criteria and Medical Assessment Framework Non-diabetic eligibility for GLP-1 therapy typically requires a BMI of 30 or higher, or 27 or higher with weight-related conditions like hypertension or dyslipidemia
Because GLP-1 drugs can increase the risk of diarrhea, nausea, and vomiting, you may need to replace fluids by rehydrating more frequently
Aspirin), and medications to manage blood clots (Ex
B12 deficiency is a documented concern with long-term GLP-1 use because these medications slow gastric emptying, which can reduce B12 absorption from food
Staying hydrated, recognizing early warning signs, and keeping your provider informed about side effects are practical steps that help reduce kidney-related risks with this medication
US$ 21.84
US$ 20.04
US$ 26.45
